4//SEC Filing
AMICUS THERAPEUTICS INC 4
Accession 0001209191-15-042022
$FOLDCIK 0001178879operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 9:42 PM ET
Size
10.8 KB
Accession
0001209191-15-042022
Insider Transaction Report
Form 4
Gershkowitz Jayne
VP, Patient Advocacy
Transactions
- Tax Payment
Common stock
2015-05-08$10.80/sh−9,307$100,516→ 15,693 total - Exercise/Conversion
Restricted stock units
2015-05-08−25,000→ 25,000 total→ Common stock (25,000 underlying) - Sale
Common stock
2015-05-11$10.84/sh−10,000$108,389→ 5,693 total - Exercise/Conversion
Common stock
2015-05-08+25,000→ 25,000 total
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2014.
- [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.73 to $10.97. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178879
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 9:42 PM ET
- Size
- 10.8 KB